AMN:NYE-AMN Healthcare Services Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 46.79

Change

+0.71 (+1.54)%

Market Cap

USD 1.75B

Volume

0.96M

Analyst Target

USD 65.38
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas. Address: 8840 Cypress Waters Boulevard, Dallas, TX, United States, 75019

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+2.39 (+0.60%)

USD 101.08B
THC Tenet Healthcare Corporation

+4.11 (+2.62%)

USD 15.77B
UHS Universal Health Services Inc

+2.41 (+1.04%)

USD 15.68B
DVA DaVita HealthCare Partners Inc

-1.06 (-0.65%)

USD 13.72B
EHC Encompass Health Corp

+1.13 (+1.24%)

USD 9.38B
CHE Chemed Corp

-0.13 (-0.02%)

USD 8.66B
ARDT Ardent Health Partners, Inc.

-0.14 (-0.81%)

USD 2.59B
NHC National HealthCare Corporatio..

-0.76 (-0.61%)

USD 1.92B
AGL agilon health Inc

+0.35 (+9.62%)

USD 1.50B
BKD Brookdale Senior Living Inc

-0.02 (-0.30%)

USD 1.33B

ETFs Containing AMN

ITEK:AU iShares Future Tech Innov.. 16.62 % 0.00 %

+0.25 (+0.92%)

N/A
2804:HK Premia MSCI Vietnam ETF 7.91 % 0.00 %

N/A

N/A
9804:HK Premia MSCI Vietnam ETF 7.44 % 0.00 %

N/A

N/A
VNAM Global X MSCI Vietnam ETF 6.36 % 0.00 %

-0.03 (0.92%)

USD 0.01B
HERS-B:CA 0.00 % 0.00 %

N/A

N/A
VNM 0.00 % 0.68 %

N/A

N/A
HERS:CA 0.00 % 0.62 %

N/A

N/A
DMRS 0.00 % 0.45 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -37.51% 14% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.51% 14% F 5% F
Trailing 12 Months  
Capital Gain -44.44% 14% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.44% 14% F 4% F
Trailing 5 Years  
Capital Gain -16.99% 33% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.99% 33% F 17% F
Average Annual (5 Year Horizon)  
Capital Gain 10.88% 59% D- 71% C-
Dividend Return 10.88% 55% F 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 44.13% 45% F 21% F
Risk Adjusted Return 24.65% 45% F 43% F
Market Capitalization 1.75B 60% D- 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector